Interpreting the role of acquired gene mutations in defining clinical outcome and treatment response.

被引:0
|
作者
Papaemmanuil, Elli [1 ]
机构
[1] Wellcome Trust Sanger Inst, Cambridge, England
关键词
D O I
10.1158/1557-3265.HEMMAL14-IA42
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA42
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Role of the inflammatory response in community-acquired pneumonia: clinical implications
    Rombauts, Alexander
    Abelenda-Alonso, Gabriela
    Cuervo, Guillermo
    Gudiol, Carlota
    Carratala, Jordi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (10) : 1261 - 1274
  • [22] The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
    Genovese, Elena
    Mirabile, Margherita
    Rontauroli, Sebastiano
    Sartini, Stefano
    Fantini, Sebastian
    Tavernari, Lara
    Maccaferri, Monica
    Guglielmelli, Paola
    Bianchi, Elisa
    Parenti, Sandra
    Carretta, Chiara
    Mallia, Selene
    Castellano, Sara
    Colasante, Corrado
    Balliu, Manjola
    Bartalucci, Niccolo
    Palmieri, Raffaele
    Ottone, Tiziana
    Mora, Barbara
    Potenza, Leonardo
    Passamonti, Francesco
    Voso, Maria Teresa
    Luppi, Mario
    Vannucchi, Alessandro Maria
    Tagliafico, Enrico
    Manfredini, Rossella
    ANTIOXIDANTS, 2022, 11 (01)
  • [23] Gene mutations or polymorphisms in association with platelet response to aspirin and/or clopidogrel and long-term clinical outcome following coronary stenting
    Kaymaz, C.
    Tanboga, I. H.
    Can, M. M.
    Tokgoz, H. C.
    Sonmez, K.
    Saglam, M.
    Ozdemir, N.
    EUROPEAN HEART JOURNAL, 2011, 32 : 244 - 244
  • [24] Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase gene mutations
    Chien, YH
    Chiang, SC
    Huang, A
    Lin, JM
    Chiu, YN
    Chou, SP
    Chu, SY
    Wang, TR
    Hwu, WL
    JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (08) : 815 - 823
  • [25] Gene expression profiles of triple negative breast cancer epithelial and stromal cells are predictive of treatment response.
    Jovanovic, Bojana
    Chen, Steven X.
    Lehmann, Brian D.
    Johnson, Kimberly N.
    Sanchez, Violeta
    Kuba, Maria G.
    Sanders, Melinda E.
    Mayer, Ingrid A.
    Moses, Harold L.
    Pietenpol, Jennifer A.
    CANCER RESEARCH, 2013, 73 (08)
  • [26] Clinical validation of the Northstar Response: A novel quantitative methylation ctDNA monitoring assay for advanced GI cancer treatment response.
    Sahin, Ilyas
    Li, Derek
    Kahramangil, Doga
    Yasinzai, Abdul Qahar K.
    Mcdaniel, Lee D.
    Cremer, Maegan
    Kim, George P.
    Rogers, Sherise C.
    Ramnaraign, Brian Hemendra
    Ferrall-Fairbanks, Meghan
    Lee, Ji-Hyun
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 839 - 839
  • [27] Defining the response to multiple sclerosis treatment: the role of conventional magnetic resonance imaging
    M. Rovaris
    M. Filippi
    Neurological Sciences, 2005, 26 : s204 - s208
  • [28] Defining the response to multiple sclerosis treatment: the role of conventional magnetic resonance imaging
    Rovaris, M
    Filippi, M
    NEUROLOGICAL SCIENCES, 2005, 26 (Suppl 4) : S204 - S208
  • [29] Interpreting patient treatment response in analgesic clinical trials: Implications for genotyping, phenotyping, and personalized pain treatment
    Dworkin, Robert H.
    McDermott, Michael P.
    Farrar, John T.
    O'Connor, Alec B.
    Senn, Stephen
    PAIN, 2014, 155 (03) : 457 - 460
  • [30] Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
    Girolami, Francesca
    Ho, Carolyn Y.
    Semsarian, Christopher
    Baldi, Massimo
    Will, Melissa L.
    Baldini, Katia
    Torricelli, Francesca
    Yeates, Laura
    Cecchi, Franco
    Ackerman, Michael J.
    Olivotto, Iacopo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (14) : 1444 - 1453